Objective: To evaluate the hepatoprotective activity of Pterocarpus marsupium stem bark extracts against carbon tetrachloride (CCl 4 )-induced hepatotoxicity. Materials and methods: Hepatotoxicity was induced in male Wistar rats by intraperitoneal injection of CCl 4 (0.1 ml/kg/day for 10 days). Methanol and aqueous extracts of P. marsupium stem bark were administered to the experimental rats (25 mg/kg/day, p.o. for 14 days). The hepatoprotective effect of these extracts was evaluated by the assay of liver function biochemical parameters (total bilirubin, serum protein, alanine aminotransaminase, aspartate aminotransaminase, and alkaline phosphatase activities) and histopathological studies of the liver. Results: In methanol extract-treated animals, the toxic effect of CCl 4 was controlled significantly by restoration of the levels of serum bilirubin, protein and enzymes as compared to the normal and the standard drug silymarin-treated groups. Histology of the liver sections of the animals treated with the extracts showed the presence of normal hepatic cords, absence of necrosis and fatty infiltration, which further evidenced the hepatoprotective activity. Conclusion: Methanol extract of the stem bark of P. marsupium possesses significant hepatoprotective activity.
Introduction
Pterocarpus marsupium Roxb. (Papilionaceae) is a deciduous tree commonly distributed in forests of the western ghats of India. [1] The plant is commonly known as Asanahm bijakah (Sanskrit), Red Kino tree (English) and Honne (Kannada). The gum obtained from the stem is used as astringent, in diarrhea and for toothache and the leaves are useful as external applications for boils, sores and skin diseases. [2] The flowers are used in fever, and the gum is locally applied in leucorrhoea and passive haemorrhage. [3] The flavonoid constituents marsupin, pterosupin and liquiritigenin were isolated from the heart wood of the plant. The therapeutic effect of these constituents was reported to possess antihyperglycemic [4] and antihyperlipidemic activities. [5] The aqueous extract of stem bark was found to reduce the blood glucose level in alloxan-induced diabetic rats. [6] The ethnic groups residing in the vicinity of the Joldhal forest ranges of Karnataka are using the stem bark of this species in treating wounds, fever, stomachache, diabetes and jaundice. Literature reviews indicated that the hepatoprotective activity of these species has not been clinically evaluated so far. An active and safe drug is needed for the treatment of hepatitis. In view of this, the present study was aimed at evaluating the hepatoprotective activity of the stem bark of P. marsupium against carbon tetrachloride (CCl 4 )-induced hepatotoxicity in albino rats.
Materials and methods
The stem bark of P. marsupium was collected from Joldhal range forest, Davanagere, Karnataka. The plant was authenticated by comparing with the herbarium voucher specimen deposited at Kuvempu University Herbaria [7] (FDD-147) Shankaraghatta. The material was air dried under shade, powdered mechanically and stored in airtight containers. About 1 kg of the powdered material was boiled with 5 l of distilled water for 30 min and filtered to obtain the aqueous extract.
[8], [9] The extract was concentrated under reduced pressure and finally dried using the water bath. Another 1 kg of the powdered material was subjected for soxhlation. It was refluxed with methanol for 48 h in batches of 250 g each. The extracts were pooled together and concentrated in vacuum using rotary flash evaporator (Buchi, Flawil, Switzerland).
Drug formulations
Oral suspensions containing 25 mg/ml of the methanol and aqueous extracts were prepared in 1% w/v gum tragacanth.
Animals
Male Wistar albino rats weighing 150-200 g were obtained from the National College of Pharmacy, Shimoga, Karnataka. They were maintained at standard housing conditions and fed with commercial diet (Hindustan Lever Ltd., Bangalore) and provided with water ad libitum during the experiment. The institutional animal ethical committee (Reg. No. 144/1999/ CPCSEA/SMG) permitted the study.
Evaluation of hepatoprotective activity
The acute toxicity studies were carried out as per stair case method.
[10] Fifty male rats were divided into five groups of 10 each and were administered with aliquot doses of the extracts orally (100, 150, 200, 250 and 300 mg/kg). Mortality was not noticed up to 200 mg/kg, whereas, 100% mortality was noticed in the dose of 300 mg/kg. The LD 50 of the extracts was found to be 250 mg/kg body weight. One-tenth of this dose was selected as the therapeutic dose for the evaluation. [11] Five groups of animals containing six each were used for the study. The animals from Group I served as the control and received the vehicle 1% w/v gum tragacanth at a dose of 1 ml/ kg/day of p.o. for 14 days. Groups II-V received 0.1 ml/kg/ day i.p. of CCl 4 (E-Merck, Mumbai, India) for 10 days.
[12] The standard drug Silymarin (Ranbaxy Lab. Dewas) was administered to Group III animals in the dose of 100 mg/kg/ day p.o. for 14 days. While, Groups IV and V were treated with methanol extract and aqueous extract of P. marsupium in the dose of 25 mg/kg/day, p.o. (as per acute toxicity studies) for 14 days, respectively. The CCl 4 , silymarin and the extracts were administered concomitantly to the respective groups of animals.
Assessment of hepatoprotective activity
All the animals were killed on day 14 under light ether anaesthesia. The blood samples were collected separately by carotid bleeding into sterilized dry centrifuge tubes and allowed to coagulate for 30 min at 37°C. The clear serum was separated at 2500 rpm for 10 min and biochemical investigations were carried out to assess liver function viz., total bilirubin, [13] total protein, [14] serum transaminases [15] and serum alkaline phosphatase [16] (Raichem, San Diego, CA 92111-1203).
The results are expressed as mean±SEM of six animals from each group. The data were evaluated by one-way ANOVA followed by Tukey's multiple comparison test. P values <0.01 were considered statistically significant. Histopathology After draining the blood, liver samples were excised, washed with normal saline and processed separately for histological observations. Initially, the materials were fixed in 10% buffered neutral formalin for 48 h and then with bovine solution for 6 h. Paraffin sections were taken at 5 mm thickness, processed in alcohol-xylene series and were stained with alum hematoxylin and eosin.
[17] The sections were examined microscopically for histopathological changes.
Results
The administration of CCl 4 to the animals resulted in a marked increase in total bilirubin, serum amino transaminases (AST and ALT) and serum alkaline phosphatase activities. However, the serum total protein level was decreased. The toxic effect of CCl 4 was controlled in the animals treated with the methanol and aqueous extracts by way of restoration of the levels of the liver function biochemistry similar to that of the standard drug silymarin (Table 1) . Among the extract- treated groups, significant hepatoprotective activity, was observed in those treated with methanol extract. Histological profile of the control animals showed normal hepatocytes (Fig. 1) . Group II animals exhibited intense centrilobular necrosis (N), vacuolization (F) and macrovesicular fatty change (Fig. 2) . The sections of liver taken from the animals treated with standard drug silymarin showed the hepatic architecture, which was similar to that of control (Fig.  3) . The animals treated with methanol extract exhibited significant liver protection against the toxicant as evident by the presence of normal hepatic cords, absence of necrosis and lesser fatty infiltration (Fig. 4) . However, moderate accumulation of fatty lobules (Fig. 5) was noticed in the sections of animals treated with the aqueous extract.
Discussion
The CCl 4 has been used as a tool to induce hepatotoxicity in experimental animals. [18] , [19] This toxic chemical caused peroxidative degradation in the adipose tissue resulting in fatty infiltration of the hepatocytes. The increase in the levels of serum bilirubin reflected the depth of jaundice and the increase in transaminases and alkaline phosphatase was the clear indication of cellular leakage and loss of functional integrity of the cell membrane. [20] Administration of methanol extract and aqueous extract of P. marsupium stem bark showed significant hepatoprotective activity, which was comparable with the standard drug silymarin. The effect was more pronounced with methanol extract. Many phytochemical reports revealed that the methanolic extract of the plant was found to contain higher concentrations of flavonoids and glycosides. [21] The qualitative phytochemical investigations on the methanolic extracts of P. marsupium also showed positive for flavonoids by ferric chloride, alkaline reagent and Shinoda tests. Further, it has been reported that the flavonoid constituents of the plant possess antioxidant properties [22] and was found to be useful in the treatment of liver damage. [23] The administration of hepatoprotective drugs may induce the hepatocytes to resist the toxic effect of CCl 4 . The results indicate that the methanolic extract of P. marsupium has significant hepatoprotective activity. This may be probably due to the higher content of flavonoids. The earlier investigators [24] have screened the hepatoprotective activity of the flavonoid compound, rutin, isolated from Artemisia scoparia, which is also claimed to have free radical scavenging and antilipid peroxidant activities against CCl 4 -induced hepatic toxicity. The isolation and characterization of the flavonoids from the stem bark of P. marsupium and screening of the pharmacological action against the liver damage is being investigated. In most of the developed and developing countries, the incidence of viral hepatitis is more so, the investigation for an efficient hepatoprotective drug from the natural resource is an urgent necessity.
